KUALA LUMPUR, 18 May 2026 — BREGO Life Sciences will kick off BREGO Cares 2026: Stronger Bones, Better Health, a community bone health screening initiative that will bring earlier assessment closer to where Malaysians already seek routine care, primary care clinics, through the rollout of VeriOsteo OP, an AI-assisted bone mineral density screening software.
In conjunction with Osteoporosis Awareness Month, the programme will run from May to June 2026 and is planned to reach communities across Klang Valley, Negeri Sembilan, Kedah, Pahang, Johor, Terengganu and Kelantan, as well as Sabah and Sarawak, bringing earlier bone health assessment closer to communities beyond major city centres.
Osteoporosis is often called a “silent disease” because bone loss can progress without symptoms until a fracture occurs. Globally, 1 in 3 women and 1 in 5 men over the age of 50 are at risk of osteoporotic fractures in their lifetime. While DEXA scans remain the gold standard for diagnosis, these services in Malaysia are still largely concentrated in major hospitals and specialist centres, making early screening less accessible for many communities.
A Malaysian survey of primary care physicians found that only 27.7% actively practised osteoporosis screening, with 90.6% citing limited access to bone mineral densitometry (such as DEXA) as a key barrier. BREGO Cares responds to this gap by testing how AI-assisted screening can bring earlier risk assessment closer to primary care. By leveraging existing X-ray capability in clinics, the approach reduces reliance on specialist referrals and separate appointments—making preventive bone health checks more feasible within routine care.
“In primary care, we often only discover bone health issues after a fall or fracture,” said Dr. Tan Cheng Lu, General Practitioner at O2 Klinik Sri Petaling.
“If we can make screening more accessible at the clinic level, we can start the conversation earlier and guide patients on what to do next, before serious complications happen.”
Danny Wong, Founder of BREGO Life Sciences shared “BREGO Cares is our commitment to improving access to preventive healthcare through innovative and accessible solutions, especially where early screening gaps still exist. For bone health, the challenge has never been awareness alone, it has been access. This initiative is designed to close that gap by enabling earlier screening in neighbourhood clinics.”
Track A will host half-day bone health screening sessions, offering chest X-rays with VeriOsteo assessment, alongside complimentary SelecK2 and/or Recardis samples (Calcium and Vitamin D supplements) provided based on bone health assessment outcomes. Track A sites include O2 Klinik (Sri Petaling, Kuala Lumpur), Klinik Hayat Subang Perdana (Selangor), Klinik Utama Jugra (Selangor), Klinik Adam Hawa Paroi (Negeri Sembilan), Klinik Rohana & Seripah (Terengganu), Klinik Remedic (Kedah), Permai Polyclinics Lok Kawi (Sabah), PMG Medical Clinic (Sarawak) & more.
Track B will broaden community reach through free Vitamin D screening using fingerstick tests with on-the-spot results, supported by practical education on bone health risk factors and recommended follow-up pathways. Track B sites include SEGi Healthcare (Selangor), Klinik Medilove Keponggi (Kuala Lumpur), Klinik Kwan & Chong (Kuala Lumpur), Poliklinik Ar Razi (Pahang), Klinik Adam Hawa Bera (Pahang) Klinik Primer Cherang (Kelantan), Klinik Perubatan Hijraa (Terengganu), Klinik Medina Seremban 2 (Negeri Sembilan)
BREGO Cares builds on its wider community health efforts and will continue to explore additional preventive health initiatives over time. First confirmed screening date: O2 Klinik (Sri Petaling) — 21 May 2026. For updates on upcoming clinic schedules and participation, visit www.brego.com.my or contact info@brego.com.my.
About BREGO Life Sciences
BREGO Life Sciences is a Malaysian healthcare company dedicated to enhancing lives through innovative, clinically proven therapies. Founded in 2015, BREGO specialises in musculoskeletal and nerve health solutions, delivering proprietary products like MobithronⓇ Advance, BionervⓇ to over 2,000 clinics and major hospitals across Malaysia.
With a strong presence in both private and public healthcare sectors, BREGO combines scientific evidence, in-house innovation and compassionate access to care. Through its BREGO Cares initiative, the company has extended treatment support to underprivileged communities across Malaysia, helping to improve mobility and quality of life for patients in need.
Its Powering Mobility program further reinforces this commitment by delivering ongoing medical education in collaboration with hospitals and medical societies.
BREGO Cares is BREGO Life Sciences’ corporate social responsibility initiative committed to improving access to preventive healthcare through innovative and accessible solutions, with a focus on bridging gaps in early screening, awareness and community care.